This early-stage study tested a new vaccine designed to prevent disease caused by the Zika virus. About 150 healthy adults who had never been infected with similar viruses received one of several different dose levels of the experimental vaccine. The main goals were to see how sa…
Phase: PHASE1 • Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 17, 2026 13:09 UTC